• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

茶多酚在肝细胞癌中的化学预防和治疗潜力。

Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, Northeast Ohio Medical University, Rootstown, Ohio, USA.

出版信息

Nutr Cancer. 2013;65(3):329-44. doi: 10.1080/01635581.2013.767367.

DOI:10.1080/01635581.2013.767367
PMID:23530632
Abstract

The prophylactic and therapeutic properties of tea have been attributed to green tea catechins and black tea theaflavins besides several other polyphenolic compounds. Tea polyphenols possess potent antioxidant and antiinflammatory properties and modulate several signaling pathways. These biochemical facets of tea polyphenols are responsible for its anticancer properties. Several lethal cancers, such as liver cancer, develop within a background of oxidative stress and inflammation. Liver cancer, also known as hepatocellular carcinoma (HCC), has been shown to occur throughout the world including Asia, Africa, Western Europe, and the United States. Phytochemicals, such as tea polyphenols, provide an effective and promising alternative for the chemoprevention and treatment of HCC. In this article, we systematically review, for the first time, the effects of tea polyphenols in the preclinical in vitro and in vivo HCC models. The review also examines, in critical detail, the biochemical mechanisms involved in the chemopreventive and antineoplastic effects of tea polyphenols in hepatic cancer. Finally, we highlight the role of synergy, bioavailability and pharmacokinetics of tea polyphenols, current status of clinical trials, discuss future directions, and comment on the future challenges involved in the effective use of tea polyphenols for the prevention and management of liver cancer.

摘要

茶的预防和治疗特性归因于绿茶儿茶素和红茶茶黄素,以及其他几种多酚化合物。茶多酚具有强大的抗氧化和抗炎特性,并调节几种信号通路。这些茶多酚的生化方面是其抗癌特性的原因。几种致命的癌症,如肝癌,是在氧化应激和炎症的背景下发展起来的。肝癌,也称为肝细胞癌 (HCC),已在包括亚洲、非洲、西欧和美国在内的世界各地发生。植物化学物质,如茶多酚,为 HCC 的化学预防和治疗提供了一种有效且有前途的替代方法。在本文中,我们首次系统地综述了茶多酚在 HCC 的临床前体外和体内模型中的作用。该综述还详细检查了茶多酚在肝癌的化学预防和抗肿瘤作用中涉及的生化机制。最后,我们强调了茶多酚协同作用、生物利用度和药代动力学的作用、临床试验的现状、讨论未来的方向,并评论了有效使用茶多酚预防和管理肝癌所涉及的未来挑战。

相似文献

1
Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer.茶多酚在肝细胞癌中的化学预防和治疗潜力。
Nutr Cancer. 2013;65(3):329-44. doi: 10.1080/01635581.2013.767367.
2
Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.白藜芦醇在肝细胞癌的化学预防和治疗中的应用。
Cancer Treat Rev. 2010 Feb;36(1):43-53. doi: 10.1016/j.ctrv.2009.10.002. Epub 2009 Nov 11.
3
Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance.膳食植物化学物在肝细胞癌的化学预防和治疗中的作用:体内证据、分子靶点和临床相关性。
Curr Cancer Drug Targets. 2012 Nov 1;12(9):1191-232.
4
Tea antioxidants in cancer chemoprevention.茶抗氧化剂在癌症化学预防中的作用
J Cell Biochem Suppl. 1997;27:59-67.
5
Chemoprevention of liver cancer by plant polyphenols.植物多酚预防肝癌。
Food Chem Toxicol. 2012 Jun;50(6):2155-70. doi: 10.1016/j.fct.2012.04.002. Epub 2012 Apr 11.
6
Biotransformation of green tea polyphenols and the biological activities of those metabolites.绿茶多酚的生物转化及其代谢产物的生物活性。
Mol Pharm. 2007 Nov-Dec;4(6):819-25. doi: 10.1021/mp700075m. Epub 2007 Oct 27.
7
Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.绿茶多酚及其成分表没食子儿茶素没食子酸酯在体外和体内均能抑制人乳腺癌细胞的增殖。
Cancer Lett. 2007 Jan 8;245(1-2):232-41. doi: 10.1016/j.canlet.2006.01.027. Epub 2006 Mar 6.
8
Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.水飞蓟素与肝细胞癌:一项系统、全面且批判性的综述
Anticancer Drugs. 2015 Jun;26(5):475-86. doi: 10.1097/CAD.0000000000000211.
9
Curcumin and liver cancer: a review.姜黄素与肝癌:综述。
Curr Pharm Biotechnol. 2012 Jan;13(1):218-28. doi: 10.2174/138920112798868791.
10
Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts.植物多酚植物药复合物的生物利用度和活性:水飞蓟素、姜黄素、绿茶和葡萄籽提取物
Altern Med Rev. 2009 Sep;14(3):226-46.

引用本文的文献

1
Microbiome dysbiosis and immune checkpoint inhibitors: Dual targets in Hepatocellular carcinoma management.微生物群失调与免疫检查点抑制剂:肝细胞癌治疗中的双重靶点
World J Hepatol. 2025 Jul 27;17(7):106810. doi: 10.4254/wjh.v17.i7.106810.
2
The Safety and Efficacy of Dietary Epigallocatechin Gallate Supplementation for the Management of Obesity and Non-Alcoholic Fatty Liver Disease: Recent Updates.膳食表没食子儿没食子酸酯补充剂用于治疗肥胖症和非酒精性脂肪性肝病的安全性和有效性:最新进展
Biomedicines. 2025 Jan 15;13(1):206. doi: 10.3390/biomedicines13010206.
3
Modulation of Gut Microbial Biomarkers and Metabolites in Cancer Management by Tea Compounds.
茶化合物对癌症管理中肠道微生物生物标志物和代谢物的调节作用。
Int J Mol Sci. 2024 Jun 8;25(12):6348. doi: 10.3390/ijms25126348.
4
Dietary Polyphenols against Oxidative Stress in Head and Neck Cancer: What's New, What's Next.膳食多酚对头颈部癌氧化应激的作用:新进展与未来方向
J Cancer. 2024 Jan 1;15(2):293-308. doi: 10.7150/jca.90545. eCollection 2024.
5
An Overview of the Enhanced Effects of Curcumin and Chemotherapeutic Agents in Combined Cancer Treatments.姜黄素与化疗药物联合应用增强癌症治疗效果的概述。
Int J Mol Sci. 2023 Aug 9;24(16):12587. doi: 10.3390/ijms241612587.
6
Multiresidue Pesticide Analysis in Tea Using GC-MS/MS to Determine 12 Pesticide Residues (GB 2763-2021).茶叶中 12 种农药多残留的测定 气相色谱-串联质谱法(GB 2763-2021)
Molecules. 2022 Dec 1;27(23):8419. doi: 10.3390/molecules27238419.
7
The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products.非酒精性脂肪性肝炎驱动的肝癌发病机制及天然产物的预防和治疗作用
Front Pharmacol. 2022 Jul 7;13:944088. doi: 10.3389/fphar.2022.944088. eCollection 2022.
8
Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma.益生菌和益生元对肝细胞癌的免疫调节作用
World J Hepatol. 2022 Feb 27;14(2):372-385. doi: 10.4254/wjh.v14.i2.372.
9
Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC.遗传学、免疫和营养促进非酒精性脂肪性肝炎向肝癌的转变。
Biomedicines. 2021 Oct 23;9(11):1524. doi: 10.3390/biomedicines9111524.
10
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.肝细胞癌的免疫治疗及肠道微生物组的潜在影响。
Int J Mol Sci. 2021 Jul 21;22(15):7800. doi: 10.3390/ijms22157800.